Literature DB >> 211370

Hormonal regulation of membrane receptors and cell responsiveness: a review.

G P Tell, F Haour, J M Saez.   

Abstract

Hormone receptors are those components of target-cells that specifically bind hormones and convey the hormonal message to the intracellular machinery. Such receptors can be localized inside the cell, such as the nuclear receptors of thyroid hormones and the nuclear and cytoplasmic receptors of steroid hormones, or on the outer surface of the plasma membrane, such as the membrane-bound receptors of polypeptide hormones and neurotransmitters. Extensive studies during recent years have shown that the interaction between hormone and membrane-bound receptor can affect the receptor characteristics in at least two ways. Firstly, receptor occupancy can modify, by way of cooperativity, the affinity of homologue receptors for the given hormone. Secondly, the binding capacity of a target cell appears to vary as a function of the preexposure of the cell to the hormone. The latter phenomenon has been related to the so-called states of subsensitivity, desensitization, or refractoriness, and might be responsible for the physiologic regulation of the target cell sensitivity and for the hormone resistance which accompanies various metabolic disorders. In this review we attempt to describe the major findings related to hormone desensitization or resistance of these hormones that have plasma-membrane-bound receptors. Data from the literature are presented independently for each hormone and when applicable, conflicting results are discussed in each section. The various theories which might explain hormone desensitization are outlined in the last section of this paper.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211370     DOI: 10.1016/s0026-0495(78)80029-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

Review 1.  [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].

Authors:  W Gerok
Journal:  Klin Wochenschr       Date:  1979-06-15

2.  Catecholamines and diabetes mellitus.

Authors:  H Kather; B Simon
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

3.  Vasopressin induces selective desensitization of its mitogenic response in Swiss 3T3 cells.

Authors:  M K Collins; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

4.  Adaptation of the pituitary gland to prolonged LRH stimulation.

Authors:  T R Koiter; N Pols-Valkhof; G A Schuiling
Journal:  Experientia       Date:  1981-12-15

5.  Genetic analysis of beta-adrenergic receptor internalization and down-regulation.

Authors:  L C Mahan; A M Koachman; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Hormone-receptor interactions are noncooperative: application to the beta-adrenergic receptor.

Authors:  R J Pollet; M L Standaert; B A Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes.

Authors:  B C Reed; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Unresponsiveness of prolactin to repeated injection of sulpiride in man.

Authors:  H Cohen; M Pugeat; J Tourniaire; J Bertrand
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.

Authors:  D Giugliano; N Passariello; R Torella; T Cerciello; M Varricchio; S Sgambato
Journal:  Acta Diabetol Lat       Date:  1981

10.  Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation.

Authors:  M Kasuga; C R Kahn; J A Hedo; E Van Obberghen; K M Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.